JOIN
JARED’S
FIGHT TO END ALL
SARCOMA CANCERS
Rhabdomyosarcoma(RMS) is a rare malignant tumor that involves striated muscle tissue. RMS can affect the orbital area, the genitourinary system, head and neck, and other areas of the body. Affected areas can cause the normal system functions to fail and eventually shutdown. RMS typically affects children under 15 with a survival rate of only 20%-50%.
The research for RMS has been almost completely ignored by big pharma because of how rare the cancer is. Less research equals inadequate funds to provide the medicine for those who are diagnosed with Sarcoma. Since cases for RMS are so rare, researchers are reluctant to help provide adequate funding and medicine for the cancer.